SLX-300

N/A

Report date: 2024/05/27 17:07:04

NME

Base Information

Drug NameSLX-300

Drug Alias NameSLX-300

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsPeripheral Nervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSolaxa Inc

China Registration ClassN/A

Active CompaniesSolaxa Inc

Inactive CompaniesN/A

Active IndicationsPeripheral Nervous System Diseases

Inactive IndicationsN/A

ATC CodeN/A